Therapeutic effect of gypenoside on chronic liver injury and fibrosis induced by CC14 in rats

American Journal of Chinese Medicine

Volumn 28, Issue 2, 2000, Pages 175-185

  Chen, Jung Chou ^a   Tsai, Chin Chuan ^a   Chen, Leih Der ^b   Chcn, Hing Ho ^a   Wang, Wen Chuang ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CARBON TETRACHLORIDE; GYPENOSIDE IX; HERBACEOUS AGENT; POISON; SAPONIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXPERIMENTAL LIVER CIRRHOSIS; MALE; RAT; TOXIC HEPATITIS; WISTAR RAT;

ANIMALS; ANTILIPEMIC AGENTS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HEPATITIS, CHRONIC, DRUG-INDUCED; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; POISONS; RATS; RATS, WISTAR; SAPONINS;

EID: 0033654490     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/s0192415x00000222     Document Type: Article

References (28)

1. Bosiso, E., C. Benelli and O. Pirola. Effect of the flavonolignans of silybum marianum L. on Lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol. Res. 25: 147-154,1992.
2. Carola, D., E. Jochen and D.G. Herbert. Inhibition of kupffer cell function as an explanation for the hepatoprotective properties of silibinin. Hepatology 23(4): 749-754, 1996.
3. Cameron, G.R. and W.A.E. Karunaratne. Carbon tetrachloride cirrhosis in relation to liver regeneration. J. Palhol. Bacterial. A-42: 1-21, 1936.
4. 4 and D-galactosamine in rats. J. Chin. Med. (Taipei) 10(4): 231-247,1999.
5. Chen, J.C., J.G. Chung and L.D. Chen. Gypenoside induces apoptosis in human Hep3B and HA22T tumour cells. Cytobios. 100: 37-48, 1999.
6. Doumas, B.T., W.A. Watson and H.G. Biggs. Albumin standards and the measurement for serum albumin with bromocresol green. Clin. Chim. Ada. 31: 87-96, 1997.
7. Gabriele, B., S. Lutz, H. Hannann, W. Jürgen, O.K. Ernst and S. Detlef. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology' 26(3): 643-649, 1997.
8. Hoder, M. and J.H. Wilkinson. Enzymes in Chemical Diagnosis of Disease, 2nd printing, S.S. Brown, F.L. Mitchel and S.D. Young (eds), Amsterdam, New York, Oxford: BiomedPress, pp. 363, 1980.
9. Hruszkewycz, A.M. Destruction of microsomal cytochrome P-450 and glucose-6-phosphate by lipid extracted from peroxidized microsome. Toxicol. Appl. Pharmacol. 46: 695-702, 1978.
10. Jer, M., C.C. Lin, H.F. Chiu, J.J. Yang and S.O. Lee. Evaluation of the anti-inflammatory and liver protective effects of Anoectochilus formosanus, Ganoderma lucidum and Gynostemma pentaphyllum in rats. Am. J. Chin. Med 11(1): 59-69, 1993.
11. Jonker, A.M., F.W.J. Dijkhuis, A. Does, M.J. Hardonk and J. Grond. Immunohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats. Hepatology. 15: 423-431, 1992.
12. Jonker, A.M., F.W.J. Dijkhuis, A. Boes, M.J. Hardonk and J. Grond. Immunopathology of acute galactosamine hepatitis in rats. Hepatology 11: 622-627, 1990.
13. Woessncr, J.F. The determination of hydroxyproline in tissue and protein samples containing small proportion of this amino acid. Arch. Biochem. Biophys. 93: 440-447, 1961.
14. Laitinen, O., K.I. Kivirikko and D.J. Prockop. Clinical application of urinary hydroxyproline determination. Acta. Med. Scand. Supple, 577, 1974.
15. Mourclle, M., P. Muriel, L. Favari and T. Franco. Prevention of CCU-induced liver cirrhosis by Silymarin. Fimdam. Clin. Pharmacol. 3: 183-191, 1989.
16. 4 liver damage. J. Appl. Toxicol. 10:275-279, 1990.
17. Perez Tamayo, R. Cirrhosis of the liver : a reversible disease? In: Sommers, S.C., Rosen, P.P., eds, Pathology Annual, Vol. 2, New York: Appleton-century-crofts, pp. 183-213, 1979.
18. Perez Tamayo, R. Pathology of collagen degradation. Am. J. Patliolo. 92: 509-566, 1978.
19. 4 an adequate model of human cirrhosis? Hepatology' 3(1): 112-120, 1983.
20. Rietman, S. and S. Frankel. A colorimetric method for determination of serum glutamic oxalacetic and glutamic pyruvic transminase. Am. J. Clin. Pathol. 25: 940, 1957.
21. Ruwart, M.J., K.F. Wilkinson, B.D. Rush, T.J. Vidmar, K.M. Peters and K.S. Henley. The integrated value of serum procollagen III peptide over time predicts hepatic hydroxy-proline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 10(5): 801-806, 1989.
22. 4 hepatotoxicity. Life Sei. 33: 401-408, 1983.
23. 4 as demonstrated by the use of phenergan. Nature (London) 189: 821-829, 1961.
24. Recknagel, R.O. Carbon tetrachloride hepatotoxicity. Pharmacol. Res. 19: 145-208, 1967.
25. 4 on liver call calcium homeostasis, in Heilman C(ed): Calcium-dependent processes in the liver, London, MTP Press, Ltd, pp 229-236,1988a.
26. 4 poisoning. Exp. Mod Palhol. 5: 413-426, 1966.
27. 4 to rabbits, hid J. Med. Res. 60: 1378-1381, 1972.
28. Yasunobu, M. and M. Kunio. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/ cirrhosis. Hepatology 26(1): 81-89, 1997.